Why Double Counting Distorts Information Value
A value-of-information (VOI) calculation compares decisions made with current information against decisions that could be made with additional information. Its apparent simplicity hides an important requirement: each piece of evidence, each cost, and each future return must enter the comparison exactly once. If an observed data set has already shaped current beliefs, reusing it as if it were new evidence can make an option appear more attractive than it is. Counting a study cost twice can make a worthwhile study look unattractive; counting a future return twice can make an unwise development decision look profitable.
The safeguard is to define the current information set, the proposed new information, and the payoff for each action before calculating. This tutorial focuses on auditing those inputs. It assumes that the decision options and payoffs are well defined, and that probabilities represent uncertainty about the relevant outcomes given the information available. Where a new study is assumed to be independent of existing data conditional on the state of interest, that assumption must be defensible for the actual data sources and study design.
The word incremental is central. The current value uses the evidence that is already available. The post-study value uses that same evidence plus the genuinely new result. A study does not create information merely because its records are placed in a new file or given a new label. Conversely, a new trial can be informative even if it uses the same endpoint as an earlier study, provided its observations are genuinely new and its relationship to existing data is modeled correctly.
Three Audits Before Calculating VOI
A practical audit traces each input through the decision calculation. First, identify which observations produced the current posterior or probability-of-success estimate. Second, specify which future observations the planned study will add and how their likelihood relates to the existing observations. Third, write down the payoff consequences by decision and state, including the timing and conditions under which costs and returns occur.
- Evidence audit: Is each data set used once in forming beliefs? Is a proposed result new, or is it a duplicate or re-expression of evidence already used?
- Cost audit: Is the cost incremental and incurred under the option being evaluated? Is it already included in a net payoff or in a study budget deducted elsewhere?
- Return audit: Is a return conditional on success, already risk-adjusted, or already net of a cost? Do not apply a success probability or subtract a cost again if the payoff already incorporates it.
When a new sample is conditionally independent of existing data given \(\theta\), its likelihood can be combined with the existing likelihood. Conditional independence means that, after conditioning on \(\theta\), the joint likelihood factors into the product of the two likelihoods. This is not a default license to multiply likelihoods: overlapping participants, reused measurements, shared controls, or common data-processing steps may invalidate the factorization. A joint model for all observations, or an explicit model of their dependence, is then needed.
Worked Example: Recognizing a Reused Efficacy Result
Suppose current data include one binary result \(E\). Before observing it, the probability that a treatment is effective is \(0.40\). The chance of observing \(E\) is \(0.80\) if the treatment is effective and \(0.30\) if it is ineffective. The decision is to launch or stop. Launching pays 10 million dollars if effective and loses 6 million dollars if ineffective; stopping pays zero. A team proposes to treat a copied record of \(E\) as a second independent result.
Use the observed evidence once. Bayes' rule gives
The expected payoff from launch using this posterior is \(0.64(10)+0.36(-6)=6.40-2.16=4.24\) million dollars. Stopping has value zero, so the current optimal value is 4.24 million dollars.
The copied record contains no new observation. The correct posterior and decision value therefore remain 0.64 and 4.24 million dollars; the incremental information value of the copy is zero. To see the distortion, the prior odds are \(0.40/0.60=2/3\), and the likelihood ratio for \(E\) is \(0.80/0.30=8/3\). Incorrectly applying that same likelihood ratio twice gives odds \((2/3)(8/3)^2=128/27\), hence a false posterior probability \(128/(128+27)=128/155\approx0.8258\). The resulting launch value would be \((128/155)(10)+(27/155)(-6)=(1280-162)/155=1118/155\approx7.213\) million dollars. This increase is not a valid EVSI: it comes from pretending the same observation happened independently twice.
A genuinely new, independent study could have positive EVSI, even if it used the same test. Its possible results must be evaluated under their predictive probabilities; a duplicated, already observed result cannot be treated that way.
Justification: Free Information Cannot Reduce Decision Value
A useful check on a VOI calculation is that free information cannot reduce expected value when the decision maker can ignore it, the available actions and payoffs do not change, and the information has no other consequence. For each possible result \(Y\), the decision maker can choose the action that performs best after seeing it. The expected value of making that choice cannot be below the value of committing to the best action before seeing \(Y\).
The inequality follows because, for any fixed action, the maximum after observing \(Y\) is at least that action's conditional expected payoff; taking expectations preserves the inequality, and it holds for the best action chosen before \(Y\) as well. The equality is the law of iterated expectation. Subtracting \(V(D)\) proves that EVSI is nonnegative under these conditions. A negative computed gross EVSI is a warning to check the calculation or the assumptions. Net value can be negative because the study has a cost or other adverse consequences.
Worked Example: Valuing a New Trial After Existing Data
Suppose current evidence has already been summarized as a probability of efficacy of \(0.40\). Launching pays 10 million dollars if efficacy is present and loses 8 million dollars if it is absent; stopping pays zero. A planned trial is assumed to use new participants and to be independent of the existing data conditional on efficacy status. Its result is positive with probability \(0.80\) when efficacy is present and \(0.20\) when it is absent. The trial cost is 1.50 million dollars. Assume no delay effect or other cost, and that this trial cost is not included in the launch payoffs.
Before the trial, launch has expected value \(0.40(10)+0.60(-8)=4.00-4.80=-0.80\) million dollars, so the current best decision is to stop, worth zero. The predictive probability of a positive trial is \(0.40(0.80)+0.60(0.20)=0.44\). Given a positive result, the posterior efficacy probability is \(0.40(0.80)/0.44=8/11\). Launch then has expected value \((8/11)(10)+(3/11)(-8)=56/11\approx5.091\) million dollars, so launch is chosen.
The probability of a negative result is \(1-0.44=0.56\). Given a negative result, the posterior efficacy probability is \(0.40(0.20)/0.56=1/7\). Launch would then be worth \((1/7)(10)+(6/7)(-8)=-38/7\approx-5.429\) million dollars, so stopping is chosen. Thus the expected value with the trial result, before its cost, is \(0.44(56/11)+0.56(0)=2.24\) million dollars. Since the current value is zero, gross EVSI is 2.24 million dollars, and net value is \(2.24-1.50=0.74\) million dollars. Under these assumptions, the trial is worth undertaking.
The \(0.40\) probability is the summary of existing evidence; it is not an extra data set to be counted again. The trial likelihood updates that probability once. The cost is subtracted once because it is incremental and was not included in the payoffs. If existing participants or measurements were included in the planned trial result, the stated independent-new-data assumption would need revision.
Count Costs and Future Returns Once
Double counting can occur even when the evidence update is sound. A payoff table should make clear whether each value is gross or net, conditional or already probability-weighted, and before or after a cost. For example, if a development investment is incurred whenever a program continues, it can be included in each state-contingent continuation payoff. Alternatively, it can be subtracted once from the expected gross return. Doing both subtracts the same investment twice.
Similarly, a future return of 20 million dollars conditional on technical success contributes \(p(20)\) million dollars when the success probability is \(p\). If a reported value is already that risk-adjusted expected return, applying \(p\) again understates it. A value that is already net of development costs must not have those costs subtracted again. Costs paid before the decision and unrecoverable regardless of the chosen action are sunk for that decision; relevant future costs depend on the option being evaluated.
Worked Example: Avoiding a Second Probability Adjustment
Current evidence gives a \(0.30\) probability of technical success. Continuing requires a 2 million dollar investment and yields a 20 million dollar return if successful, with no return if unsuccessful. The investment is paid whether the program succeeds or fails. Stopping pays zero. A proposed test has sensitivity \(0.80\) and false-positive probability \(0.20\), and costs 0.30 million dollars. Assume its result is new, conditionally independent of current evidence, and has no delay consequence.
The state-contingent payoffs for continuing are \(20-2=18\) million dollars on success and \(-2\) million dollars on failure. The current expected value is \(0.30(18)+0.70(-2)=5.40-1.40=4.00\) million dollars, so continuing is preferred to stopping.
The probability of a positive test is \(0.30(0.80)+0.70(0.20)=0.38\), and the posterior success probability after a positive result is \(0.24/0.38=12/19\). Continuing then has value \((12/19)(18)+(7/19)(-2)=202/19\approx10.632\) million dollars. The negative-result probability is \(0.62\), and the posterior success probability after a negative result is \(0.30(0.20)/0.62=3/31\). Continuing after a negative result has value \((3/31)(18)+(28/31)(-2)=-2/31\approx-0.06452\) million dollars, so the decision is to stop.
Expected value after observing the test, before its cost, is \(0.38(202/19)+0.62(0)=4.04\) million dollars. Gross EVSI is therefore \(4.04-4.00=0.04\) million dollars; net value is \(0.04-0.30=-0.26\) million dollars. The test is not worthwhile on these assumptions. An equivalent current-value calculation is \(0.30(20)-2=4\) million dollars. The 20 million dollar return is conditional on success, so it is weighted by \(0.30\) once; the investment is then subtracted once. If the 6 million dollar value \(0.30(20)\) were described as an already risk-adjusted return, multiplying it by \(0.30\) again would be incorrect.
Diagnostics, Alternatives, and Limitations
Several checks help reveal double counting before a result is used in a development decision:
- Trace data provenance. List the observations behind the current probability or posterior and those expected from the proposed study. Check participant overlap, shared controls, repeated measurements, and whether a summary already incorporates the proposed data.
- Check the likelihood structure. Multiplying likelihoods is justified only when the conditional-independence model is appropriate. If observations overlap or share sources of variation, model their joint dependence instead of treating them as independent replicates.
- Reconcile the payoff table. Label each amount as conditional or expected, gross or net, and specify when it is paid. Confirm that a success probability, study cost, or development cost is not applied twice.
- Check gross EVSI. Under the conditions in the derivation, gross EVSI should not be negative. A negative result can indicate inconsistent conditioning, a calculation error, or a changed action set or payoff that violates those conditions.
- Compare with an alternative formulation. A joint-likelihood calculation updates from all data at once; a sequential calculation first updates with \(D\), then with \(Y\). When both use the same valid probability model, they should agree. A disagreement often signals duplicated evidence, inconsistent priors, or a mismatched likelihood.
Adding separate VOI estimates is not generally a substitute for evaluating the combined information. Two studies can overlap, their value can depend on which decisions are available after both, and the first study can change the usefulness of the second. The reliable comparison specifies the information available in each scenario and calculates the corresponding optimal expected value. This tutorial's calculations also assume that the decision options and payoff structure are adequately represented; misspecified payoffs, dependence, timing, or study outcomes can still produce misleading VOI even when there is no literal duplication.
Common mistake: “The trial database is separate from the existing database, so it must be independent evidence.” A separate file or analysis does not establish independence. The correction is to check what observations and sources generated each data set and to model overlap or dependence explicitly. Likewise, do not call a previously risk-adjusted return “conditional on success” and apply the success probability again: first determine what the reported amount already includes.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- A posterior probability already uses an interim analysis. The same interim observations are then entered as a “new” data set with the same likelihood. What is the problem?
- A new study is conditionally independent of existing data and has positive gross EVSI of 1.2 million dollars. Its incremental cost is 1.5 million dollars and is not otherwise included. What is its net value?
- A program has a 0.25 probability of success and a return of 12 million dollars conditional on success. What is the risk-adjusted expected return? What error results from applying the success probability to that expected return again?
- A gross EVSI calculation is negative, although the proposed information is free, can be ignored, and does not change the actions or payoffs. Name a useful diagnostic implication.
Solutions. (1) The interim observations are used twice, which generally exaggerates the evidence; retain one update or use a correctly specified joint likelihood. (2) Net value is \(1.2-1.5=-0.3\) million dollars, so the study does not pay for itself under the stated assumptions. (3) The expected return is \(0.25(12)=3\) million dollars. Multiplying 3 by 0.25 again gives 0.75 million dollars and incorrectly applies the success probability twice. (4) Check the calculation and assumptions, especially whether current and post-information values use consistent conditioning and whether the information truly leaves the action set and payoffs unchanged. Gross EVSI should be nonnegative under those conditions.